Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)

被引:7
作者
Jia, XiaoXiao [1 ,2 ]
Shi, Ming [3 ]
Wang, Qifei [1 ,2 ]
Hui, Jessica [4 ]
Shofaro, Joshua Hui [1 ,2 ]
Erkhembayar, Ryenchindorj [5 ]
Hui, Mizhou [1 ,2 ]
Gao, Chenzhe [1 ]
Gantumur, Munkh-Amgalan [1 ]
机构
[1] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China
[2] Qingdao Agr Univ, Coll Vet Med, Qingdao, Peoples R China
[3] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China
[4] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Sch Med, Stanford, CA USA
[5] Mongolian Natl Univ Med Sci, Grad Sch, Dept Int Cyber Educ, Ulaanbaatar, Mongolia
关键词
hyaluronic acid; 35kDa hyaluronic acid fragment; B-HA; HA35; molecular weight; inflammation; inflammatory cells; reactive oxygen species; injection safety; MOLECULAR-MASS; 2; DEFICIENCY; EXPRESSION; PAIN; NEUTROPHIL; MICROGLIA; SIGLEC-9; PH-20; HAS2;
D O I
10.2147/JIR.S393495
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. Methods: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. Results: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After 99mTc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. Conclusion: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies.
引用
收藏
页码:209 / 224
页数:16
相关论文
共 70 条
  • [21] Leucocyte Trafficking via the Lymphatic Vasculature - Mechanisms and Consequences
    Jackson, David G.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [22] Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking
    Jackson, David G.
    [J]. MATRIX BIOLOGY, 2019, 78-79 : 219 - 235
  • [23] Hyaluronic Acid Biomaterials for Central Nervous System Regenerative Medicine
    Jensen, Gregory
    Holloway, Julianne L.
    Stabenfeldt, Sarah E.
    [J]. CELLS, 2020, 9 (09) : 1 - 17
  • [24] Pain regulation by non-neuronal cells and inflammation
    Ji, Ru-Rong
    Chamessian, Alexander
    Zhang, Yu-Qiu
    [J]. SCIENCE, 2016, 354 (6312) : 572 - 577
  • [25] A "GC-rich" method for mammalian gene expression: A dominant role of non-coding DNA GC content in regulation of mammalian gene expression
    Jia Qian
    Wu HongTao
    Zhou XingJun
    Gao Jian
    Zhao Wei
    JouDi, Aziz
    Wei JingShuang
    Hou LiHua
    Wu ShuYin
    Zhang Ying
    Dong XiangFeng
    Huang YanMin
    Jin WeiYuan
    Zhu HongJie
    Zhao XinHui
    Huang ChunHua
    Xing LiPing
    Li LiWen
    Ma Jun
    Liu XiYan
    Tao Ran
    Ye ShuaiDong
    Song YiGao
    Song LingLing
    Chen GuanPing
    Du ChunLing
    Zhang XueTing
    Li Bo
    Wang YanTao
    Yang Wei
    Rishton, Gilbert
    Teng YuYang
    Leng GouQing
    Li LuanFeng
    Liu WenXian
    Cheng LiJun
    Liang QiuBo
    Li ZhengWu
    Zhang XiuQin
    Zuo YaJun
    Chen Wei
    Li HuiCheng
    Hui, Matthew
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2010, 53 (01) : 94 - 100
  • [26] Jia X, 2021, Chinese and PCT Patent, Patent No. 2021102700130
  • [27] A novel mechanism of erythrocyte capture from circulation in humans
    Kerfoot, Steven M.
    McRae, Krista
    Lam, Florence
    McAvoy, Erin F.
    Clark, Stephen
    Brain, Michael
    Lalor, Patricia F.
    Adams, David H.
    Kubes, Paul
    [J]. EXPERIMENTAL HEMATOLOGY, 2008, 36 (02) : 111 - 118
  • [28] Multifunctional Role of 35 Kilodalton Hyaluronan in Promoting Defense of the Intestinal Epithelium
    Kessler, Sean P.
    Obery, Dana R.
    Nickerson, Kourtney P.
    Petrey, Aaron C.
    McDonald, Christine
    de la Motte, Carol A.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2018, 66 (04) : 273 - 287
  • [29] Hyaluronan 35 kDa treatment protects mice from Citrobacter rodentium infection and induces epithelial tight junction protein ZO-1 in vivo
    Kim, Yeojung
    Kessler, Sean P.
    Obery, Dana R.
    Homer, Craig R.
    McDonald, Christine
    de la Motte, Carol A.
    [J]. MATRIX BIOLOGY, 2017, 62 : 28 - 39
  • [30] Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease
    Kiser, Zachary M.
    Lizcano, Anel
    Nguyen, Julia
    Becker, Greta L.
    Belcher, John D.
    Varki, Ajit P.
    Vercellotti, Gregory M.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2020, 81